Why take this course?
AI adoption is moving into regulated quality operations, including automated quality reviews, predictive maintenance, complaint handling, CAPA management, and AI-assisted decision processes. The FDA’s first AI-related Warning Letter signals that AI-enabled activities cannot sit outside the Quality Management System. They must be validated, controlled, monitored, documented, and governed with the same seriousness expected for other GMP-impacting systems.
For quality, regulatory, validation, IT, and operational teams, the issue is no longer whether AI can support efficiency, but whether its use can withstand regulatory review. Data integrity, validation, risk management, change control, supplier oversight, human accountability, cybersecurity, bias, hallucinations, and model drift all become quality system concerns when AI affects regulated decisions. This webinar addresses how organizations can integrate AI into existing QMS processes while reducing compliance gaps and preparing for FDA inspection questions involving AI-driven technologies.
Key Areas Covered
Dr. Ginette Collazo
Ginette Collazo, Ph. D. has 20 years of experience in Engineering Psychology, Human Reliability, training, and human error reduction within pharmaceutical and medical device manufacturing. Her work in investigations, cause determination, CAPA development, effectiveness, and critical quality situations connects directly to AI oversight, human accountability, deviation handling, and quality system control.
Ready to Strengthen Your Team? Let’s Build Your Training Plan.
Your team deserves the clarity.
Your organization deserves the confidence.
Upcoming Courses
Your TalkFDA Webinar Experience
1. Confirmation
3. Join the Live Training
4. Watch Again Anytime
Testimonials


